Edition:
United States

Europe News Headlines

FILE PHOTO: Syringes are seen in front of displayed Biontech and Pfizer...

Instant View: Pfizer ends COVID-19 trial with 95% efficacy

Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.

Politics Video

Politics News